Drug developers weigh building internal radiopharmaceutical capabilities versus outsourcing amid timeline and funding ...
Explore the latest news and expert commentary by Steven Gravallese, brought to you by the Contributor of BioProcess ...
Explore the latest news and expert commentary by Stephen Cheng, brought to you by the Contributor of BioProcess International ...
Bioprocessing professionals tackle costs of single-use systems and disposable equipment after pandemic-driven price spikes in ...
Biopharma facility qualification ensures production environments, utility systems, and equipment meet regulations for new ...
Explore how life-science companies adapt office spaces to balance hybrid work flexibility with the need for innovation, ...
Learn how relative quantification provides coverage of the total host cell protein population, enabling assessment of process ...
Lonza partners with ImmuneOncia to manufacture Danburstotug, a promising mAb therapy for rare NK/T-cell lymphoma, advancing ...
Explore how biopharmaceutical companies are navigating capital constraints, rising R&D costs, and regulatory demands amid ...
Abselion debuts its US subsidiary in Cambridge and highlights its Amperia platform at BPI West, advancing biopharma ...
Samsung Biologics acquires GSK’s Rockville site, boosting US capacity by 60,000 liters and advancing supply-chain resilience ...
Moving away from fed-batch has significant sustainability and cost-saving benefits, according to industry working groups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results